An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer

Annals of Thoracic Surgery

Volumn 73, Issue 1, 2002, Pages 259-266

  Akhurst, Tim ^a,b,c   Downey, Robert J ^a,d   Ginsberg, Michelle S ^a,d   Gonen, Mithat ^a,d   Bains, Manjit ^a,d   Korst, Robert ^a,d   Ginsberg, Robert J ^a,d   Rusch, Valerie W ^a,d   Larson, Steven M ^a,d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c Thirty seventh Annual Meeting of The Society of Thoracic Surgeons   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG NEOPLASMS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036148550     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)03257-X     Document Type: Article

References (22)

1. H.C Steinert M Hauser F Allemann Non-small cell lung cancer nodal staging with FDG-PET versus CT with correlative lymph node mapping and sampling Radiology 202 1997 441 446
2. J.F Vansteenkiste S.G Stroobants P.R De Leyn Lymph node staging in non-small-cell lung cancer with FDG-PET scan a prospective study on 690 lymph node stations from 68 patients J Clin Oncol 16 1998 2142 2149
3. S.U Berlangieri A.M Scott S.R Knight F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer Eur J Cardiothorac Surg 16 Suppl 1 1999 S25 S30
4. R.L Wahl L.E Quint R.L Greenough C.R Meyer R.I White M.B Orringer Staging of mediastinal non-small cell lung cancer with FDG-PET, CT, and fusion images preliminary prospective evaluation Radiology 191 1994 371 377
5. B.A Dwamena S.S Sonnad J.O Angobaldo R.L Wahl Metastases from non-small cell lung cancer mediastinal staging in the 1990s–meta-analytic comparison of PET and CT Radiology 213 1999 530 536
6. Y Fong P.F Saldinger T Akhurst Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases Am J Surg 178 1999 282 287
7. J.F Vansteenkiste S.G Stroobants P.R De Leyn P.J Dupont E.K Verbeken Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer a prospective pilot study. The Leuven Lung Cancer Group Ann Oncol 9 1998 1193 1198
8. N Martini M.G Kris R.J Gralla The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0) Ann Thorac Surg 45 1988 370 379
9. J.A Roth E.N Atkinson F Fossella Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy, and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer 21 1998 1 6
10. D.J Adelstein T.W Rice L.A Rybicki Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small-cell lung cancer Am J Clin Oncol 22 1999 237 242
11. R Rosell J Gomez-Codina C Camps Preresectional chemotherapy in stage IIIA non-small-cell lung cancer a 7-year assessment of a randomized controlled trial Lung Cancer 26 1999 7 14
12. K.M Pisters M.G Kris R.J Gralla M.B Zaman R.T Heelan N Martini Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy implications for the design of future non-small-cell lung cancer combined modality trials J Clin Oncol 11 1993 1757 1762
13. N Martini M.G Kris B.J Flehinger Preoperative chemotherapy for stage IIIa (N2) lung cancer the Sloan-Kettering experience with 136 patients Ann Thorac Surg 55 1993 1365 1374
14. A.D Elias A.T Skarin T Leong Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC) Lung Cancer 17 1997 147 161
15. K.S Lee Y.M Shim J Han Primary tumors and mediastinal lymph nodes after neoadjuvant concurrent chemoradiotherapy of lung cancer serial CT findings with pathologic correlation J Comput Assist Tomogr 24 2000 35 40
16. R.J Lewis G.E Sisler J.W Mackenzie Repeat mediastinoscopy Ann Thorac Surg 37 1984 147 149
17. M Pauwels P Van Schil W De Backer F Van den Brande E Eyskens Repeat mediastinoscopy in the staging of lung cancer Eur J Cardiothorac Surg 14 1998 271 273
18. M Mateu-Navarro R Rami-Porta R Bastus-Piulats L Cirera-Nogueras G Gonzalez-Pont Remediastinoscopy after induction chemotherapy in non-small cell lung cancer Ann Thorac Surg 70 2000 391 395
19. C.F Mountain Revisions in the International System for Staging Lung Cancer [see Comments] Chest 111 1997 1710 1717
20. J.F Vansteenkiste S.G Stroobants P.R De Leyn Lymph node staging in non-small cell lung cancer with FDG-PET scan a prospective study on 690 lymph node stations from 68 patients Clin Oncol 16 1998 2142 2149
21. J.F Vansteenkiste S.G Stroobants P.R De Leyn P.J Dupont E.K Verbeken Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small cell lung cancer a prospective pilot study. The Leuven Lung Cancer Group Ann Oncol 9 1998 1193 1198
22. C.D Ramos Y.E Erdi M Gonen FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back projection Eur J Nucl Med 28 2001 155 164